Eczema
Conditions
Keywords
Group eczema education
Brief summary
The objective of this study is to determine whether group educational visits improve the quality of life of patients referred to the Dermatology Clinic. Secondary outcomes will be to determine whether group educational visits influences other key elements of patient care such as topical steroid usage, disease exacerbations, emergency visits, and phone calls to the office. Lastly, the investigators hope to evaluate which aspects of the educational visit were found to be the most helpful to families caring for children with atopic dermatitis (AD). Patients will be new atopic dermatitis referrals to OHSU dermatology and pediatric dermatology clinics. All consecutive patients with such appointments during a three month time period will be screened for participation in the study. Parents will be recruited via telephone. In the intervention group, parents will be invited to participate in a group education visit prior to their first appointment with a dermatologist. All parents in the study will fill out questionnaires. The children involved in the study will be assigned an eczema severity score during their routine visits, but this will be incorporated into the regular clinic assessment. The Childhood Atopic Dermatitis Impact Scale (CADIS) assesses the quality of life in households with children who have atopic dermatitis. The Eczema Area and Severity Index (EASI) measures the extent and severity of the patient's atopic dermatitis. The change in CADIS scores will be analyzed to determine if there is a more significant improvement in quality of life for the group in which parents receive the group eczema education visit.
Interventions
OTHERGroup eczema education session
Subjects in the intervention group will participate in a group education visit to discuss topics such as subjects' general understanding and knowledge of eczema and its treatment.
OTHERControl group
The control group will not attend the group eczema education session.
Sponsors
Oregon Health and Science University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
2 Months to 6 Years
Healthy volunteers
No
Inclusion criteria
* Children ages 2 months though 6 years. * Participants must carry a diagnosis of atopic dermatitis according to the Hanifin and Rajka criteria. * New patients or consultations at an OHSU clinic. * English-speaking families will be included in this study
Exclusion criteria
* Subjects who have been on systemic therapies for treatment of their atopic dermatitis (prednisone or cyclosporine)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The difference between the two groups in CADIS score | 4 weeks | The primary outcome will be the difference between the two groups in CADIS score as measured at four weeks. CADIS is a validated outcome of pediatric quality of life in AD. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assess extent of skin disease. | Between 4 weeks and 4 months of the first visit. | EASI (Eczema Area and Severity Index) scores will be performed to assess extent of skin disease at an interval between 4 weeks and 4 months of the first visit. |
| Assess average monthly number of follow-up phone calls. | Between 4 weeks and 4 months of the first visit. | A chart review will be done to assess average monthly number of follow-up phone calls. |
| Assess average monthly number of urgent and emergency visits. | Between 4 weeks and 4 months of the first visit. | A chart review will be done to assess average monthly number of urgent and emergency visits. |
Countries
United States
Outcome results
None listed